Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1975 6
1976 1
1977 4
1978 4
1979 5
1980 4
1981 2
1982 4
1983 10
1984 7
1985 4
1986 7
1987 3
1988 5
1989 7
1990 4
1991 6
1992 5
1993 6
1994 4
1995 3
1996 5
1997 7
1998 5
1999 5
2000 2
2001 3
2002 4
2003 5
2004 5
2005 8
2006 10
2007 8
2008 7
2009 15
2010 30
2011 15
2012 24
2013 22
2014 18
2015 20
2016 26
2017 31
2018 36
2019 23
2020 31
2021 37
2022 36
2023 45
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

555 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.
Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR; DMD Care Considerations Working Group. Birnkrant DJ, et al. Lancet Neurol. 2018 Mar;17(3):251-267. doi: 10.1016/S1474-4422(18)30024-3. Epub 2018 Feb 3. Lancet Neurol. 2018. PMID: 29395989 Free PMC article. Review.
Since the publication of the Duchenne muscular dystrophy (DMD) care considerations in 2010, multidisciplinary care of this severe, progressive neuromuscular disease has evolved. ...In 2014, a steering committee of experts from a wide range of di …
Since the publication of the Duchenne muscular dystrophy (DMD) care considerations in 2010, multidisciplinary …
Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.
Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S, Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM; DMD Care Considerations Working Group. Birnkrant DJ, et al. Lancet Neurol. 2018 Apr;17(4):347-361. doi: 10.1016/S1474-4422(18)30025-5. Epub 2018 Feb 3. Lancet Neurol. 2018. PMID: 29395990 Free PMC article. Review.
A coordinated, multidisciplinary approach to care is essential for optimum management of the primary manifestations and secondary complications of Duchenne muscular dystrophy (DMD). Contemporary care has been shaped by the availability of more s …
A coordinated, multidisciplinary approach to care is essential for optimum management of the primary manifestations and secondary com …
Consensus on the diagnosis, treatment and follow-up of patients with Duchenne muscular dystrophy.
Nascimento Osorio A, Medina Cantillo J, Camacho Salas A, Madruga Garrido M, Vilchez Padilla JJ. Nascimento Osorio A, et al. Neurologia (Engl Ed). 2019 Sep;34(7):469-481. doi: 10.1016/j.nrl.2018.01.001. Epub 2018 Mar 9. Neurologia (Engl Ed). 2019. PMID: 29526319 Free article. English, Spanish.
INTRODUCTION: Duchenne muscular dystrophy (DMD) is the most common myopathy in children, with a worldwide prevalence of approximately 0.5 cases per 10,000 male births. ...Genetic studies play a key role in the management of the disease, both in detecting case …
INTRODUCTION: Duchenne muscular dystrophy (DMD) is the most common myopathy in children, with a worldwide prevalence of …
CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases.
Sharma G, Sharma AR, Bhattacharya M, Lee SS, Chakraborty C. Sharma G, et al. Mol Ther. 2021 Feb 3;29(2):571-586. doi: 10.1016/j.ymthe.2020.09.028. Epub 2020 Sep 20. Mol Ther. 2021. PMID: 33238136 Free PMC article. Review.
This comprehensive review paper discusses the origin of CRISPR-Cas9 systems and their therapeutic potential against various genetic disorders, including cancer, allergy, immunological disorders, Duchenne muscular dystrophy, cardiovascular disorders, ne …
This comprehensive review paper discusses the origin of CRISPR-Cas9 systems and their therapeutic potential against various genetic d …
Update of the Brazilian consensus recommendations on Duchenne muscular dystrophy.
Araujo APQC, Saute JAM, Fortes CPDD, França MC Jr, Pereira JA, Albuquerque MAV, Carvalho AAS, Cavalcanti EBU, Covaleski APPM, Fagondes SC, Gurgel-Giannetti J, Gonçalves MVM, Martinez ARM, Coimbra Neto AR, Neves FR, Nucci A, Nucera APCDS, Pessoa ALS, Rebel MF, Santos FND, Scola RH, Sobreira CFDR. Araujo APQC, et al. Arq Neuropsiquiatr. 2023 Jan;81(1):81-94. doi: 10.1055/s-0043-1761466. Epub 2023 Mar 14. Arq Neuropsiquiatr. 2023. PMID: 36918011 Free PMC article. Review.
In the last few decades, there have been considerable improvements in the diagnosis and care of Duchenne muscular dystrophy (DMD), the most common childhood muscular dystrophy. ...Since the previous publication, diagnosis, steroid treatme …
In the last few decades, there have been considerable improvements in the diagnosis and care of Duchenne muscular dy …
Diagnosis and management of Becker muscular dystrophy: the French guidelines.
Magot A, Wahbi K, Leturcq F, Jaffre S, Péréon Y, Sole G; French BMD working group. Magot A, et al. J Neurol. 2023 Oct;270(10):4763-4781. doi: 10.1007/s00415-023-11837-5. Epub 2023 Jul 9. J Neurol. 2023. PMID: 37422773 Free article. Review.
Becker muscular dystrophy (BMD) is one of the most frequent among neuromuscular diseases, affecting approximately 1 in 18,000 male births. It is linked to a genetic mutation on the X chromosome. In contrast to Duchenne muscular dystrophy, for wh …
Becker muscular dystrophy (BMD) is one of the most frequent among neuromuscular diseases, affecting approximately 1 in 18,000 …
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C; DMD Care Considerations Working Group. Bushby K, et al. Lancet Neurol. 2010 Jan;9(1):77-93. doi: 10.1016/S1474-4422(09)70271-6. Epub 2009 Nov 27. Lancet Neurol. 2010. PMID: 19945913 Review.
Duchenne muscular dystrophy (DMD) is a severe, progressive disease that affects 1 in 3600-6000 live male births. Although guidelines are available for various aspects of DMD, comprehensive clinical care recommendations do not exist. The US Centers for …
Duchenne muscular dystrophy (DMD) is a severe, progressive disease that affects 1 in 3600-6000 live male births. Althou …
Corticosteroids for the treatment of Duchenne muscular dystrophy.
Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY. Matthews E, et al. Cochrane Database Syst Rev. 2016 May 5;2016(5):CD003725. doi: 10.1002/14651858.CD003725.pub4. Cochrane Database Syst Rev. 2016. PMID: 27149418 Free PMC article. Review.
BACKGROUND: Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy of childhood. ...AUTHORS' CONCLUSIONS: Moderate quality evidence from RCTs indicates that corticosteroid therapy in DMD improves muscle strength and funct …
BACKGROUND: Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy of childhood. ...AUTH …
Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan.
Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Colvin MK, Cripe L, Herron AR, Kennedy A, Kinnett K, Naprawa J, Noritz G, Poysky J, Street N, Trout CJ, Weber DR, Ward LM; DMD Care Considerations Working Group. Birnkrant DJ, et al. Lancet Neurol. 2018 May;17(5):445-455. doi: 10.1016/S1474-4422(18)30026-7. Epub 2018 Feb 2. Lancet Neurol. 2018. PMID: 29398641 Free PMC article. Review.
Improvements in the function, quality of life, and longevity of patients with Duchenne muscular dystrophy (DMD) have been achieved through a multidisciplinary approach to management across a range of health-care specialties. In part 3 of this update of …
Improvements in the function, quality of life, and longevity of patients with Duchenne muscular dystrophy (DMD) have be …
Rehabilitation Management of the Patient With Duchenne Muscular Dystrophy.
Case LE, Apkon SD, Eagle M, Gulyas A, Juel L, Matthews D, Newton RA, Posselt HF. Case LE, et al. Pediatrics. 2018 Oct;142(Suppl 2):S17-S33. doi: 10.1542/peds.2018-0333D. Pediatrics. 2018. PMID: 30275246
Steadily improving management of Duchenne muscular dystrophy (DMD) continues to lead to improved physical and functional status, allowing increasingly successful transitions to independence and self-actualization in adulthood. Rehabilitation principles remain …
Steadily improving management of Duchenne muscular dystrophy (DMD) continues to lead to improved physical and functiona …
555 results